Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (301)

« Back to Publications

ntifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.

Champaneria R. et al, (2026), Cochrane Database Syst Rev, 2

cute upper gastrointestinal bleeding in the UK: 2022 audit update.

Nigam GB. et al, (2025), Gut

BO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with meta-analysis.

Cain L. et al, (2025), Transfus Med Rev

Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial.

Derde L. et al, (2025), Thorax, 80, 530 - 539

The 2024 international survey of platelet products and practice.

Ohto H. et al, (2025), Transfus Apher Sci, 64

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial.

Hoffmann S. et al, (2025), EBioMedicine, 113

Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial.

Nurmi V. et al, (2025), J Infect, 90

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial.

TREATT Trial Investigators ., (2025), Lancet Haematol, 12, e14 - e22

International Forum on Global Patient Blood Management: Summary.

Dhiman Y. et al, (2025), Vox Sang, 120, 80 - 88

International Forum on Global Patient Blood Management: Responses.

Dhiman Y. et al, (2025), Vox Sang, 120, 89 - 103

Protocol and Statistical analysis plan for the TREATT trial

Estcourt L., (2024)

Universal irradiation of platelets: Does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?

Cain L. et al, (2024), Transfus Med Rev, 38

Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination.

Mosavie M. et al, (2024), Vaccines (Basel), 12

Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines.

Callum J. et al, (2024), Chest, 166, 321 - 338

Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.

Radford M. et al, (2024), Cochrane Database Syst Rev, 5

Load More

1
2
3
4
5
6
7
...
»